SHOULDER INNOVATIONS, INC. (SI) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SI currently has 20.7M outstanding shares. with moderate dilution risk from 5.75M authorized shares representing 27.8% potential dilution. The company has significantly diluted shareholders by 37.87% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 20.7M shares outstanding |
21M | 5.8M |
| Nov 12, 2025 |
10-Q filing | 20.6M shares outstanding |
21M | 5.8M |
| Sep 09, 2025 |
10-Q filing | 20.4M shares outstanding |
20M | 5.8M |
| Jul 25, 2025 |
S-1/A filing: S-1/A filing for an offering of common stock with an underwriter's over-allotment option. The company intends to use the net proceeds from this offering (i) to scale up our commercial organization through the hiring of additional sales representatives and expansion of our commercial leadership team, as well as to invest in additional instrument sets, (ii) to fund the research and development of continued general innovation in our implant systems and (iii) for working capital and other general corporate purposes. |
15M | 5.8M |
| Jul 24, 2025 |
S-1/A filing: This S-1/A filing outlines the offering of common stock, including an underwriter's over-allotment option, and details the company's plans for the use of proceeds, including scaling up the commercial organization, funding research and development, and for working capital. |
15M | 5.8M |
| Jul 09, 2025 |
S-1/A filing: This is an S-1/A filing for an initial public offering of common stock. |
N/A | 0 |